---
schema_version: "secwatch.filing_event.v1"
accession: "0001199835-21-000793"
form_type: "8-K"
ticker: "FTSP"
cik: "0001319643"
company_name: "FinTrade Sherpa, Inc."
filed_at: "2022-01-03T23:59:59+00:00"
generated_at: "2026-06-27T21:17:42.643451+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Lode-Star Mining acquires patented EGCG molecule assets from Sapir Pharmaceuticals for $1M in preferred stock

## Summary
- Acquired all assets related to stabilized EGCG molecule for pharmaceutical development.
- Consideration: 1,000,000 Series A Convertible Preferred shares valued at $1.00 each, convertible to common at 450:1.
- Sapir receives 5% royalty on gross revenues from licensed or derived products; paid quarterly for 5 years, extendable.
- Sapir gets 450 votes per preferred share; restrictions on reverse splits and new preferred issuance for one year.
- Transaction closed Dec 28, 2021; press release issued Dec 30, 2021.

## SEC filing metadata
- accession: 0001199835-21-000793
- form_type: 8-K
- ticker: FTSP
- cik: 0001319643
- company_name: FinTrade Sherpa, Inc.
- filed_at: 2022-01-03T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1319643/000119983521000793/0001199835-21-000793-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1319643/000119983521000793/lsmg_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001199835-21-000793
- JSON: https://secwatch.observer/filing/0001199835-21-000793.json
- Plain text: https://secwatch.observer/filing/0001199835-21-000793.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.